{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:42:59Z","timestamp":1786552979299,"version":"build-2736575974"},"reference-count":88,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Talent Development Foundation of The First Dongguan Affiliated Hospital of Guangdong Medical University","award":["No. PF100-2-02"],"award-info":[{"award-number":["No. PF100-2-02"]}]},{"name":"Higher Education Reform Project of Guangdong Province","award":["2019268"],"award-info":[{"award-number":["2019268"]}]},{"name":"Innovation Team Project of Guangdong Province Regular Higher Education Institutions","award":["No. 2025KCXTD018"],"award-info":[{"award-number":["No. 2025KCXTD018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Interdiscip Sci Comput Life Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s12539-026-00835-6","type":"journal-article","created":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T07:42:28Z","timestamp":1780299748000},"page":"1145-1164","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Unveiling the Impact of Copper Metabolism on Epithelial-Mesenchymal Transition of Triple-Negative Breast Cancer: Identification of Therapeutic Targets"],"prefix":"10.1007","volume":"18","author":[{"given":"Kai","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Waqas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haixin","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoqi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinshi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5821-703X","authenticated-orcid":false,"given":"Zunnan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"835_CR1","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.ymthe.2017.10.020","volume":"26","author":"L Liu","year":"2018","unstructured":"Liu L, Wang Y, Miao L et al (2018) Combination immunotherapy of MUC1 mRNA nano-vaccine and CTLA-4 blockade effectively inhibits growth of triple negative breast cancer. Mol Ther 26:45\u201355. https:\/\/doi.org\/10.1016\/j.ymthe.2017.10.020","journal-title":"Mol Ther"},{"key":"835_CR2","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2021.12773","volume":"22","author":"M Manjunath","year":"2021","unstructured":"Manjunath M, Choudhary B (2021) Triple-negative breast cancer: a run-through of features, classification and current therapies. Oncol Lett 22:512. https:\/\/doi.org\/10.3892\/ol.2021.12773","journal-title":"Oncol Lett"},{"key":"835_CR3","doi-asserted-by":"publisher","first-page":"916","DOI":"10.3390\/cancers12040916","volume":"12","author":"E Vagia","year":"2020","unstructured":"Vagia E, Mahalingam D, Cristofanilli M (2020) The landscape of targeted therapies in TNBC. Cancers 12:916. https:\/\/doi.org\/10.3390\/cancers12040916","journal-title":"Cancers"},{"key":"835_CR4","doi-asserted-by":"publisher","first-page":"957","DOI":"10.3390\/cells8090957","volume":"8","author":"M Nedeljkovic","year":"2019","unstructured":"Nedeljkovic M, Damjanovic A (2019) Mechanisms of chemotherapy resistance in triple-negative breast cancer-how we can rise to the challenge. Cells 8:957. https:\/\/doi.org\/10.3390\/cells8090957","journal-title":"Cells"},{"key":"835_CR5","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2022.108253","volume":"237","author":"JY So","year":"2022","unstructured":"So JY, Ohm J, Lipkowitz S et al (2022) Triple negative breast cancer (TNBC): non-genetic tumor heterogeneity and immune microenvironment: emerging treatment options. Pharmacol Ther 237:108253. https:\/\/doi.org\/10.1016\/j.pharmthera.2022.108253","journal-title":"Pharmacol Ther"},{"key":"835_CR6","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1126\/science.abf0529","volume":"375","author":"P Tsvetkov","year":"2022","unstructured":"Tsvetkov P, Coy S, Petrova B et al (2022) Copper induces cell death by targeting lipoylated TCA cycle proteins. Science 375:1254\u20131261. https:\/\/doi.org\/10.1126\/science.abf0529","journal-title":"Science"},{"key":"835_CR7","doi-asserted-by":"publisher","first-page":"R421","DOI":"10.1016\/j.cub.2021.03.054","volume":"31","author":"T Tsang","year":"2021","unstructured":"Tsang T, Davis CI, Brady DC (2021) Copper biology. Curr Biol 31:R421\u2013R427. https:\/\/doi.org\/10.1016\/j.cub.2021.03.054","journal-title":"Curr Biol"},{"key":"835_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-27559-z","volume":"12","author":"D Ramchandani","year":"2021","unstructured":"Ramchandani D, Berisa M, Tavarez DA et al (2021) Copper depletion modulates mitochondrial oxidative phosphorylation to impair triple negative breast cancer metastasis. Nat Commun 12:7311. https:\/\/doi.org\/10.1038\/s41467-021-27559-z","journal-title":"Nat Commun"},{"key":"835_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-023-01083-7","volume":"13","author":"EM Poursani","year":"2023","unstructured":"Poursani EM, Mercatelli D, Raninga P et al (2023) Copper chelation suppresses epithelial-mesenchymal transition by inhibition of canonical and non-canonical TGF-\u03b2 signaling pathways in cancer. Cell Biosci 13:132. https:\/\/doi.org\/10.1186\/s13578-023-01083-7","journal-title":"Cell Biosci"},{"key":"835_CR10","doi-asserted-by":"publisher","first-page":"303","DOI":"10.2217\/nnm-2021-0374","volume":"17","author":"Y Jiang","year":"2022","unstructured":"Jiang Y, Huo Z, Qi X et al (2022) Copper-induced tumorcell death mechanisms and antitumor theragnostic applications of copper complexes. Nanomedicine 17:303\u2013324. https:\/\/doi.org\/10.2217\/nnm-2021-0374","journal-title":"Nanomedicine"},{"key":"835_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1038\/s41571-024-00876-0","volume":"21","author":"D Tang","year":"2024","unstructured":"Tang D, Kroemer G, Kang R (2024) Targeting cuproplasia and cuproptosis in cancer. Nat Rev Clin Oncol 21:370\u2013388. https:\/\/doi.org\/10.1038\/s41571-024-00876-0","journal-title":"Nat Rev Clin Oncol"},{"key":"835_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.770115","volume":"9","author":"F Duan","year":"2021","unstructured":"Duan F, Li J, Huang J et al (2021) Establishment and validation of prognostic nomograms based on serum copper level for patients with early-stage triple-negative breast cancer. Front Cell Dev Biol 9:770115. https:\/\/doi.org\/10.3389\/fcell.2021.770115","journal-title":"Front Cell Dev Biol"},{"key":"835_CR13","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jnutbio.2013.08.013","volume":"25","author":"QF Li","year":"2014","unstructured":"Li QF, Ding XQ, Kang YJ (2014) Copper promotion of angiogenesis in isolated rat aortic ring: role of vascular endothelial growth factor. J Nutr Biochem 25:44\u201349. https:\/\/doi.org\/10.1016\/j.jnutbio.2013.08.013","journal-title":"J Nutr Biochem"},{"key":"835_CR14","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1158\/1535-7163.MCT-18-0667","volume":"18","author":"O Karginova","year":"2019","unstructured":"Karginova O, Weekley CM, Raoul A et al (2019) Inhibition of copper transport induces apoptosis in triple-negative breast cancer cells and suppresses tumor angiogenesis. Mol Cancer Ther 18:873\u2013885. https:\/\/doi.org\/10.1158\/1535-7163.MCT-18-0667","journal-title":"Mol Cancer Ther"},{"key":"835_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbamcr.2020.118893","volume":"1868","author":"VC Shanbhag","year":"2021","unstructured":"Shanbhag VC, Gudekar N, Jasmer K et al (2021) Copper metabolism as a unique vulnerability in cancer. Biochimica et Biophysica Acta (BBA) - Mol Cell Res 1868:118893. https:\/\/doi.org\/10.1016\/j.bbamcr.2020.118893","journal-title":"Biochimica et Biophysica Acta (BBA) - Mol Cell Res"},{"key":"835_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1040668","volume":"13","author":"W Chang","year":"2022","unstructured":"Chang W, Li H, Zhong L et al (2022) Development of a copper metabolism-related gene signature in lung adenocarcinoma. Front Immunol 13:1040668. https:\/\/doi.org\/10.3389\/fimmu.2022.1040668","journal-title":"Front Immunol"},{"key":"835_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.955336","volume":"12","author":"S Zhang","year":"2022","unstructured":"Zhang S, Zhang L, Lu H et al (2022) A cuproptosis and copper metabolism-related gene prognostic index for head and neck squamous cell carcinoma. Front Oncol 12:955336. https:\/\/doi.org\/10.3389\/fonc.2022.955336","journal-title":"Front Oncol"},{"key":"835_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics14020128","volume":"14","author":"PN Srinivasu","year":"2024","unstructured":"Srinivasu PN, Sirisha U, Sandeep K et al (2024) An interpretable approach with explainable AI for heart stroke prediction. Diagnostics 14:128. https:\/\/doi.org\/10.3390\/diagnostics14020128","journal-title":"Diagnostics (Basel)"},{"key":"835_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s40537-020-00316-7","volume":"7","author":"T Bikku","year":"2020","unstructured":"Bikku T (2020) Multi-layered deep learning perceptron approach for health risk prediction. J Big Data 7:50. https:\/\/doi.org\/10.1186\/s40537-020-00316-7","journal-title":"J Big Data"},{"key":"835_CR20","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.csbj.2014.11.005","volume":"13","author":"K Kourou","year":"2015","unstructured":"Kourou K, Exarchos TP, Exarchos KP et al (2015) Machine learning applications in cancer prognosis and prediction. Comput Struct Biotechnol J 13:8\u201317. https:\/\/doi.org\/10.1016\/j.csbj.2014.11.005","journal-title":"Comput Struct Biotechnol J"},{"key":"835_CR21","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1016\/j.canlet.2019.12.007","volume":"471","author":"S Huang","year":"2020","unstructured":"Huang S, Yang J, Fong S et al (2020) Artificial intelligence in cancer diagnosis and prognosis: opportunities and challenges. Cancer Lett 471:61\u201371. https:\/\/doi.org\/10.1016\/j.canlet.2019.12.007","journal-title":"Cancer Lett"},{"key":"835_CR22","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1016\/j.cell.2018.03.059","volume":"173","author":"A Blum","year":"2018","unstructured":"Blum A, Wang P, Zenklusen JC (2018) Snapshot: TCGA-analyzed tumors. Cell 173:530. https:\/\/doi.org\/10.1016\/j.cell.2018.03.059","journal-title":"Cell"},{"key":"835_CR23","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R et al (2011) Molecular signatures database (MSigDB) 3.0. Bioinformatics 27:1739\u20131740. https:\/\/doi.org\/10.1093\/bioinformatics\/btr260","journal-title":"Bioinformatics"},{"key":"835_CR24","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H et al (2015) The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst 1:417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004","journal-title":"Cell Syst"},{"key":"835_CR25","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK et al (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102","journal-title":"Proc Natl Acad Sci U S A"},{"key":"835_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101102","volume":"11","author":"K Zhuang","year":"2024","unstructured":"Zhuang K, Tang S, Feng H et al (2024) A novel copper metabolism-related signature model for predicting the prognosis, target drugs, and immunotherapy in stomach adenocarcinoma. Genes Dis 11:101102. https:\/\/doi.org\/10.1016\/j.gendis.2023.101102","journal-title":"Genes Dis"},{"key":"835_CR27","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha VK, Lindgren CM, Eriksson KF et al (2003) PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat Genet 34:267\u2013273. https:\/\/doi.org\/10.1038\/ng1180","journal-title":"Nat Genet"},{"key":"835_CR28","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/nature08460","volume":"462","author":"DA Barbie","year":"2009","unstructured":"Barbie DA, Tamayo P, Boehm JS et al (2009) Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature 462:108\u2013112. https:\/\/doi.org\/10.1038\/nature08460","journal-title":"Nature"},{"key":"835_CR29","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1613\/jair.953","volume":"16","author":"NV Chawla","year":"2002","unstructured":"Chawla NV, Bowyer KW, Hall LO et al (2002) SMOTE: synthetic minority over-sampling technique. J Artif Intell Res 16:321\u2013357. https:\/\/doi.org\/10.1613\/jair.953","journal-title":"J Artif Intell Res"},{"key":"835_CR30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41580-021-00407-0","volume":"23","author":"JG Greener","year":"2022","unstructured":"Greener JG, Kandathil SM, Moffat L et al (2022) A guide to machine learning for biologists. Nat Rev Mol Cell Biol 23:40\u201355. https:\/\/doi.org\/10.1038\/s41580-021-00407-0","journal-title":"Nat Rev Mol Cell Biol"},{"key":"835_CR31","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.medj.2021.04.006","volume":"2","author":"L Adlung","year":"2021","unstructured":"Adlung L, Cohen Y, Mor U et al (2021) Machine learning in clinical decision making. Medicine 2:642\u2013665. https:\/\/doi.org\/10.1016\/j.medj.2021.04.006","journal-title":"Medicine"},{"key":"835_CR32","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1093\/bioinformatics\/bty721","volume":"35","author":"D Toro-Dominguez","year":"2019","unstructured":"Toro-Dominguez D, Martorell-Marugan J, Lopez-Dominguez R et al (2019) ImaGEO: integrative gene expression meta-analysis from GEO database. Bioinformatics 35:880\u2013882. https:\/\/doi.org\/10.1093\/bioinformatics\/bty721","journal-title":"Bioinformatics"},{"key":"835_CR33","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","volume":"13","author":"G Bianchini","year":"2016","unstructured":"Bianchini G, Balko JM, Mayer IA et al (2016) Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease. Nat Rev Clin Oncol 13:674\u2013690. https:\/\/doi.org\/10.1038\/nrclinonc.2016.66","journal-title":"Nat Rev Clin Oncol"},{"key":"835_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.722828","volume":"11","author":"P Yu","year":"2021","unstructured":"Yu P, Zhu L, Cui K et al (2021) B4GALNT2 gene promotes proliferation, and invasiveness and migration abilities of model triple negative breast cancer (TNBC) cells by interacting with HLA-B protein. Front Oncol 11:722828. https:\/\/doi.org\/10.3389\/fonc.2021.722828","journal-title":"Front Oncol"},{"key":"835_CR35","first-page":"519","volume":"12","author":"Q Chen","year":"2020","unstructured":"Chen Q, Xia R, Zheng W et al (2020) Metronomic paclitaxel improves the efficacy of PD-1 monoclonal antibodies in breast cancer by transforming the tumor immune microenvironment. Am J Transl Res 12:519\u2013530","journal-title":"Am J Transl Res"},{"key":"835_CR36","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.annonc.2024.10.012","volume":"36","author":"M Martin","year":"2025","unstructured":"Martin M, Stecklein SR, Gluz O et al (2025) TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy. Ann Oncol 36:158\u2013171. https:\/\/doi.org\/10.1016\/j.annonc.2024.10.012","journal-title":"Ann Oncol"},{"key":"835_CR37","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/annonc\/mdy127","volume":"29","author":"F Poggio","year":"2018","unstructured":"Poggio F, Bruzzone M, Ceppi M et al (2018) Platinum-based neoadjuvant chemotherapy in triple-negative breast cancer: a systematic review and meta-analysis. Ann Oncol 29:1497\u20131508. https:\/\/doi.org\/10.1093\/annonc\/mdy127","journal-title":"Ann Oncol"},{"key":"835_CR38","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD014805.pub2","author":"SR Mason","year":"2023","unstructured":"Mason SR, Willson ML, Egger SJ et al (2023) Platinum-based chemotherapy for early triple-negative breast cancer. Cochrane Database Syst Rev. https:\/\/doi.org\/10.1002\/14651858.CD014805.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"835_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-023-01497-3","volume":"16","author":"S Zhu","year":"2023","unstructured":"Zhu S, Wu Y, Song B et al (2023) Recent advances in targeted strategies for triple-negative breast cancer. J Hematol Oncol 16:100. https:\/\/doi.org\/10.1186\/s13045-023-01497-3","journal-title":"J Hematol Oncol"},{"key":"835_CR40","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41587-020-0707-9","volume":"39","author":"L Cui","year":"2021","unstructured":"Cui L, Gouw AM, LaGory EL et al (2021) Mitochondrial copper depletion suppresses triple-negative breast cancer in mice. Nat Biotechnol 39:357\u2013367. https:\/\/doi.org\/10.1038\/s41587-020-0707-9","journal-title":"Nat Biotechnol"},{"key":"835_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-022-10393-x","volume":"22","author":"P Zhu","year":"2022","unstructured":"Zhu P, Liu G, Wang X et al (2022) Transcription factor c-Jun modulates GLUT1 in glycolysis and breast cancer metastasis. BMC Cancer 22:1283. https:\/\/doi.org\/10.1186\/s12885-022-10393-x","journal-title":"BMC Cancer"},{"key":"835_CR42","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0526-7","volume":"30","author":"Y Cirak","year":"2013","unstructured":"Cirak Y, Sarsik B, Cakar B et al (2013) Predictive and prognostic values of Tau and BubR1 protein in prostate cancer and their relationship to the Gleason score. Med Oncol 30:526. https:\/\/doi.org\/10.1007\/s12032-013-0526-7","journal-title":"Med Oncol"},{"key":"835_CR43","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbrc.2016.11.100","volume":"482","author":"N Mishra","year":"2017","unstructured":"Mishra N, Timilsina U, Ghimire D et al (2017) Downregulation of cytochrome c oxidase subunit 7A1 expression is important in enhancing cell proliferation in adenocarcinoma cells. Biochem Biophys Res Commun 482:713\u2013719. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.100","journal-title":"Biochem Biophys Res Commun"},{"key":"835_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7819-11-199","volume":"11","author":"GY Liang","year":"2013","unstructured":"Liang GY, Lu SX, Xu G et al (2013) Expression of metallothionein and Nrf2 pathway genes in lung cancer and cancer-surrounding tissues. World J Surg Oncol 11:199. https:\/\/doi.org\/10.1186\/1477-7819-11-199","journal-title":"World J Surg Oncol"},{"key":"835_CR45","doi-asserted-by":"publisher","DOI":"10.3892\/or.2021.8154","volume":"46","author":"CY Chang","year":"2021","unstructured":"Chang CY, Wu KL, Chang YY et al (2021) Amine oxidase, copper containing 3 exerts anti\u2011mesenchymal transformation and enhances CD4(+) T\u2011cell recruitment to prolong survival in lung cancer. Oncol Rep 46:203. https:\/\/doi.org\/10.3892\/or.2021.8154","journal-title":"Oncol Rep"},{"key":"835_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00380-2","volume":"27","author":"JP Li","year":"2022","unstructured":"Li JP, Liu YJ, Zeng SH et al (2022) Identification of COX4I2 as a hypoxia-associated gene acting through FGF1 to promote EMT and angiogenesis in CRC. Cell Mol Biol Lett 27:76. https:\/\/doi.org\/10.1186\/s11658-022-00380-2","journal-title":"Cell Mol Biol Lett"},{"key":"835_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-019-0164-y","volume":"24","author":"L Zhu","year":"2019","unstructured":"Zhu L, Chen L (2019) Progress in research on paclitaxel and tumor immunotherapy. Cell Mol Biol Lett 24:40. https:\/\/doi.org\/10.1186\/s11658-019-0164-y","journal-title":"Cell Mol Biol Lett"},{"key":"835_CR48","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s40265-020-01275-2","volume":"80","author":"S Dhillon","year":"2020","unstructured":"Dhillon S (2020) Avapritinib: first approval. Drugs 80:433\u2013439. https:\/\/doi.org\/10.1007\/s40265-020-01275-2","journal-title":"Drugs"},{"key":"835_CR49","doi-asserted-by":"publisher","first-page":"12383","DOI":"10.1021\/acsnano.3c01792","volume":"17","author":"D Hao","year":"2023","unstructured":"Hao D, Meng Q, Li C et al (2023) A paclitaxel prodrug with copper depletion for combined therapy toward triple-negative breast cancer. ACS Nano 17:12383\u201312393. https:\/\/doi.org\/10.1021\/acsnano.3c01792","journal-title":"ACS Nano"},{"issue":"Suppl","key":"835_CR50","doi-asserted-by":"publisher","DOI":"10.1158\/1538-7445.Am2015-791","volume":"75","author":"EK Evans","year":"2015","unstructured":"Evans EK, Hodous BL, Gardino AK et al (2015) Abstract 791: BLU-285, the first selective inhibitor of PDGFR\u03b1 D842V and KIT Exon 17 mutants. Cancer Res 75(Suppl):791. https:\/\/doi.org\/10.1158\/1538-7445.Am2015-791","journal-title":"Cancer Res"},{"key":"835_CR51","unstructured":"U.S. Food and Drug Administration (2020) FDA approves avapritinib for gastrointestinal stromal tumor with a rare mutation. Accessed 28 July 2025. https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-avapritinib-gastrointestinal-stromal-tumor-rare-mutation"},{"key":"835_CR52","unstructured":"Onconova Therapeutics I (2021) Study of ON 123300 in patients with advanced cancer. Accessed 14 August 2025. https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04739293"},{"key":"835_CR53","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/leu.2015.185","volume":"30","author":"SK Divakar","year":"2016","unstructured":"Divakar SK, Ramana Reddy MV, Cosenza SC et al (2016) Dual inhibition of CDK4\/Rb and PI3K\/AKT\/mTOR pathways by ON123300 induces synthetic lethality in mantle cell lymphomas. Leukemia 30:86\u201393. https:\/\/doi.org\/10.1038\/leu.2015.185","journal-title":"Leukemia"},{"key":"835_CR54","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1158\/2159-8290.CD-18-0484","volume":"8","author":"A Drilon","year":"2018","unstructured":"Drilon A, Ou SI, Cho BC et al (2018) Repotrectinib (TPX-0005) is a next-generation ROS1\/TRK\/ALK inhibitor that potently inhibits ROS1\/TRK\/ALK solvent front mutations. Cancer Discov 8:1227\u20131236. https:\/\/doi.org\/10.1158\/2159-8290.CD-18-0484","journal-title":"Cancer Discov"},{"key":"835_CR55","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1200\/JCO.19.02654","volume":"38","author":"J Desai","year":"2020","unstructured":"Desai J, Gan H, Barrow C et al (2020) Phase I, open-label, dose-escalation\/dose-expansion study of Lifirafenib (BGB-283), an RAF family kinase inhibitor, in patients with solid tumors. J Clin Oncol 38:2140\u20132150. https:\/\/doi.org\/10.1200\/JCO.19.02654","journal-title":"J Clin Oncol"},{"key":"835_CR56","doi-asserted-by":"publisher","first-page":"5090","DOI":"10.1158\/1078-0432.CCR-11-3200","volume":"18","author":"K Jhaveri","year":"2012","unstructured":"Jhaveri K, Miller K, Rosen L et al (2012) A phase I dose-escalation trial of trastuzumab and alvespimycin hydrochloride (KOS-1022; 17 DMAG) in the treatment of advanced solid tumors. Clin Cancer Res 18:5090\u20135098. https:\/\/doi.org\/10.1158\/1078-0432.CCR-11-3200","journal-title":"Clin Cancer Res"},{"key":"835_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2023.114791","volume":"163","author":"D Guan","year":"2023","unstructured":"Guan D, Zhao L, Shi X et al (2023) Copper in cancer: from pathogenesis to therapy. Biomed Pharmacother 163:114791. https:\/\/doi.org\/10.1016\/j.biopha.2023.114791","journal-title":"Biomed Pharmacother"},{"key":"835_CR58","doi-asserted-by":"publisher","first-page":"505","DOI":"10.7150\/ijbs.18834","volume":"13","author":"S Yu","year":"2017","unstructured":"Yu S, Cai X, Wu C et al (2017) Targeting HSP90-HDAC6 regulating network implicates precision treatment of breast cancer. Int J Biol Sci 13:505\u2013517. https:\/\/doi.org\/10.7150\/ijbs.18834","journal-title":"Int J Biol Sci"},{"key":"835_CR59","doi-asserted-by":"publisher","first-page":"4613","DOI":"10.3892\/mmr.2016.5815","volume":"14","author":"AS Guo","year":"2016","unstructured":"Guo AS, Huang YQ, Ma XD et al (2016) Mechanism of G9a inhibitor BIX\u201101294 acting on U251 glioma cells. Mol Med Rep 14:4613\u20134621. https:\/\/doi.org\/10.3892\/mmr.2016.5815","journal-title":"Mol Med Rep"},{"key":"835_CR60","doi-asserted-by":"publisher","first-page":"2126","DOI":"10.4161\/auto.26308","volume":"9","author":"Y Kim","year":"2013","unstructured":"Kim Y, Kim YS, Kim DE et al (2013) BIX-01294 induces autophagy-associated cell death via EHMT2\/G9a dysfunction and intracellular reactive oxygen species production. Autophagy 9:2126\u20132139. https:\/\/doi.org\/10.4161\/auto.26308","journal-title":"Autophagy"},{"key":"835_CR61","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.7150\/jca.48310","volume":"12","author":"L Xu","year":"2021","unstructured":"Xu L, Gao X, Yang P et al (2021) EHMT2 inhibitor BIX-01294 induces endoplasmic reticulum stress mediated apoptosis and autophagy in diffuse large B-cell lymphoma cells. J Cancer 12:1011\u20131022. https:\/\/doi.org\/10.7150\/jca.48310","journal-title":"J Cancer"},{"key":"835_CR62","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.bbrc.2021.12.089","volume":"590","author":"S Liu","year":"2022","unstructured":"Liu S, Jiang Y, Yang H et al (2022) BIX-01294 enhances the effect of chemotherapy on colorectal cancer by inhibiting the expression of stemness genes. Biochem Biophys Res Commun 590:169\u2013176. https:\/\/doi.org\/10.1016\/j.bbrc.2021.12.089","journal-title":"Biochem Biophys Res Commun"},{"key":"835_CR63","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1158\/0008-5472.CAN-15-2934","volume":"76","author":"D Perumal","year":"2016","unstructured":"Perumal D, Kuo PY, Leshchenko VV et al (2016) Dual targeting of CDK4 and ARK5 using a novel kinase inhibitor ON123300 exerts potent anticancer activity against multiple myeloma. Cancer Res 76:1225\u20131236. https:\/\/doi.org\/10.1158\/0008-5472.CAN-15-2934","journal-title":"Cancer Res"},{"key":"835_CR64","doi-asserted-by":"publisher","first-page":"2189","DOI":"10.1158\/1535-7163.MCT-21-0126","volume":"20","author":"TJ O'Donohue","year":"2021","unstructured":"O\u2019Donohue TJ, Ibanez G, Coutinho DF et al (2021) Translational strategies for repotrectinib in neuroblastoma. Mol Cancer Ther 20:2189\u20132197. https:\/\/doi.org\/10.1158\/1535-7163.MCT-21-0126","journal-title":"Mol Cancer Ther"},{"key":"835_CR65","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1158\/1535-7163.MCT-15-0262","volume":"14","author":"Z Tang","year":"2015","unstructured":"Tang Z, Yuan X, Du R et al (2015) BGB-283, a novel RAF kinase and EGFR inhibitor, displays potent antitumor activity in BRAF-mutated colorectal cancers. Mol Cancer Ther 14:2187\u20132197. https:\/\/doi.org\/10.1158\/1535-7163.MCT-15-0262","journal-title":"Mol Cancer Ther"},{"key":"835_CR66","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1080\/15384047.2015.1040964","volume":"16","author":"Y Hu","year":"2015","unstructured":"Hu Y, Bobb D, He J et al (2015) The HSP90 inhibitor alvespimycin enhances the potency of telomerase inhibition by imetelstat in human osteosarcoma. Cancer Biol Ther 16:949\u2013957. https:\/\/doi.org\/10.1080\/15384047.2015.1040964","journal-title":"Cancer Biol Ther"},{"key":"835_CR67","doi-asserted-by":"publisher","DOI":"10.1186\/bcr2416","volume":"11","author":"E Tomaskovic-Crook","year":"2009","unstructured":"Tomaskovic-Crook E, Thompson EW, Thiery JP (2009) Epithelial to mesenchymal transition and breast cancer. Breast Cancer Res 11:213. https:\/\/doi.org\/10.1186\/bcr2416","journal-title":"Breast Cancer Res"},{"key":"835_CR68","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-85379-z","volume":"11","author":"N Petruk","year":"2021","unstructured":"Petruk N, Tuominen S, Akerfelt M et al (2021) CD73 facilitates EMT progression and promotes lung metastases in triple-negative breast cancer. Sci Rep 11:6035. https:\/\/doi.org\/10.1038\/s41598-021-85379-z","journal-title":"Sci Rep"},{"key":"835_CR69","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s13402-022-00738-w","volume":"46","author":"A Vitaliti","year":"2023","unstructured":"Vitaliti A, Roccatani I, Iorio E et al (2023) AKT-driven epithelial-mesenchymal transition is affected by copper bioavailability in HER2 negative breast cancer cells via a LOXL2-independent mechanism. Cell Oncol 46:93\u2013115. https:\/\/doi.org\/10.1007\/s13402-022-00738-w","journal-title":"Cell Oncol (Dordr)"},{"key":"835_CR70","doi-asserted-by":"publisher","DOI":"10.1038\/srep12410","volume":"5","author":"S Li","year":"2015","unstructured":"Li S, Zhang J, Yang H et al (2015) Copper depletion inhibits CoCl2-induced aggressive phenotype of MCF-7 cells via downregulation of HIF-1 and inhibition of Snail\/Twist-mediated epithelial-mesenchymal transition. Sci Rep 5:12410. https:\/\/doi.org\/10.1038\/srep12410","journal-title":"Sci Rep"},{"key":"835_CR71","doi-asserted-by":"publisher","first-page":"9228","DOI":"10.1158\/0008-5472.CAN-09-1950","volume":"69","author":"H Chen","year":"2009","unstructured":"Chen H, Zhu G, Li Y et al (2009) Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining Slug expression. Cancer Res 69:9228\u20139235. https:\/\/doi.org\/10.1158\/0008-5472.CAN-09-1950","journal-title":"Cancer Res"},{"key":"835_CR72","doi-asserted-by":"publisher","first-page":"16068","DOI":"10.1074\/jbc.M116.723767","volume":"291","author":"K Raychaudhuri","year":"2016","unstructured":"Raychaudhuri K, Chaudhary N, Gurjar M et al (2016) 14-3-3\u03c3 gene loss leads to activation of the epithelial to mesenchymal transition due to the stabilization of c-Jun protein. J Biol Chem 291:16068\u201316081. https:\/\/doi.org\/10.1074\/jbc.M116.723767","journal-title":"J Biol Chem"},{"key":"835_CR73","doi-asserted-by":"publisher","first-page":"3188","DOI":"10.1172\/JCI128313","volume":"130","author":"T Gagliano","year":"2020","unstructured":"Gagliano T, Shah K, Gargani S et al (2020) PIK3Cdelta expression by fibroblasts promotes triple-negative breast cancer progression. J Clin Invest 130:3188\u20133204. https:\/\/doi.org\/10.1172\/JCI128313","journal-title":"J Clin Invest"},{"key":"835_CR74","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12051307","volume":"12","author":"A Sebastian","year":"2020","unstructured":"Sebastian A, Hum NR, Martin KA et al (2020) Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer. Cancers 12:1307. https:\/\/doi.org\/10.3390\/cancers12051307","journal-title":"Cancers"},{"key":"835_CR75","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104683","volume":"153","author":"KGK Deepak","year":"2020","unstructured":"Deepak KGK, Vempati R, Nagaraju GP et al (2020) Tumor microenvironment: challenges and opportunities in targeting metastasis of triple negative breast cancer. Pharmacol Res 153:104683. https:\/\/doi.org\/10.1016\/j.phrs.2020.104683","journal-title":"Pharmacol Res"},{"key":"835_CR76","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines9121921","volume":"9","author":"F Mollah","year":"2021","unstructured":"Mollah F, Varamini P (2021) Overcoming therapy resistance and relapse in TNBC: emerging technologies to target breast cancer-associated fibroblasts. Biomedicines 9:1921. https:\/\/doi.org\/10.3390\/biomedicines9121921","journal-title":"Biomedicines"},{"key":"835_CR77","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2020.119769","volume":"235","author":"H Xu","year":"2020","unstructured":"Xu H, Hu M, Liu M et al (2020) Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials 235:119769. https:\/\/doi.org\/10.1016\/j.biomaterials.2020.119769","journal-title":"Biomaterials"},{"key":"835_CR78","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20200712","volume":"218","author":"M Sharma","year":"2021","unstructured":"Sharma M, Turaga RC, Yuan Y et al (2021) Simultaneously targeting cancer-associated fibroblasts and angiogenic vessel as a treatment for TNBC. J Exp Med 218:e20200712. https:\/\/doi.org\/10.1084\/jem.20200712","journal-title":"J Exp Med"},{"key":"835_CR79","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1038\/s41388-019-1014-0","volume":"39","author":"JS Sung","year":"2020","unstructured":"Sung JS, Kang CW, Kang S et al (2020) ITGB4-mediated metabolic reprogramming of cancer-associated fibroblasts. Oncogene 39:664\u2013676. https:\/\/doi.org\/10.1038\/s41388-019-1014-0","journal-title":"Oncogene"},{"key":"835_CR80","doi-asserted-by":"publisher","first-page":"4635","DOI":"10.7150\/jca.28583","volume":"9","author":"J Zhou","year":"2018","unstructured":"Zhou J, Wang XH, Zhao YX et al (2018) Cancer-associated fibroblasts correlate with tumor-associated macrophages infiltration and lymphatic metastasis in triple negative breast cancer patients. J Cancer 9:4635\u20134641. https:\/\/doi.org\/10.7150\/jca.28583","journal-title":"J Cancer"},{"key":"835_CR81","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1080\/14737140.2021.1840984","volume":"21","author":"J Sukumar","year":"2021","unstructured":"Sukumar J, Gast K, Quiroga D et al (2021) Triple-negative breast cancer: promising prognostic biomarkers currently in development. Expert Rev Anticancer Ther 21:135\u2013148. https:\/\/doi.org\/10.1080\/14737140.2021.1840984","journal-title":"Expert Rev Anticancer Ther"},{"key":"835_CR82","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.redox.2018.03.007","volume":"16","author":"S Masaldan","year":"2018","unstructured":"Masaldan S, Clatworthy SAS, Gamell C et al (2018) Copper accumulation in senescent cells: interplay between copper transporters and impaired autophagy. Redox Biol 16:322\u2013331. https:\/\/doi.org\/10.1016\/j.redox.2018.03.007","journal-title":"Redox Biol"},{"key":"835_CR83","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00757","volume":"10","author":"Y Liubomirski","year":"2019","unstructured":"Liubomirski Y, Lerrer S, Meshel T et al (2019) Tumor-Stroma-Inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer. Front Immunol 10:757. https:\/\/doi.org\/10.3389\/fimmu.2019.00757","journal-title":"Front Immunol"},{"key":"835_CR84","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1080\/15548627.2023.2200554","volume":"19","author":"Q Xue","year":"2023","unstructured":"Xue Q, Kang R, Klionsky DJ et al (2023) Copper metabolism in cell death and autophagy. Autophagy 19:2175\u20132195. https:\/\/doi.org\/10.1080\/15548627.2023.2200554","journal-title":"Autophagy"},{"key":"835_CR85","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-019-0770-1","volume":"12","author":"T Liu","year":"2019","unstructured":"Liu T, Han C, Wang S et al (2019) Cancer-associated fibroblasts: an emerging target of anti-cancer immunotherapy. J Hematol Oncol 12:86. https:\/\/doi.org\/10.1186\/s13045-019-0770-1","journal-title":"J Hematol Oncol"},{"key":"835_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.938123","volume":"12","author":"Y Mao","year":"2022","unstructured":"Mao Y, Zhuo R, Ma W et al (2022) Fibroblasts mediate the angiogenesis of pheochromocytoma by increasing COX4I2 expression. Front Oncol 12:938123. https:\/\/doi.org\/10.3389\/fonc.2022.938123","journal-title":"Front Oncol"},{"key":"835_CR87","doi-asserted-by":"publisher","first-page":"E2162","DOI":"10.1073\/pnas.1603534113","volume":"113","author":"LT Hsia","year":"2016","unstructured":"Hsia LT, Ashley N, Ouaret D et al (2016) Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers. Proc Natl Acad Sci U S A 113:E2162-E2171. https:\/\/doi.org\/10.1073\/pnas.1603534113","journal-title":"Proc Natl Acad Sci U S A"},{"key":"835_CR88","doi-asserted-by":"publisher","first-page":"7680","DOI":"10.1038\/sj.onc.1205883","volume":"21","author":"Y Liu","year":"2002","unstructured":"Liu Y, Ludes-Meyers J, Zhang Y et al (2002) Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth. Oncogene 21:7680\u20137689. https:\/\/doi.org\/10.1038\/sj.onc.1205883","journal-title":"Oncogene"}],"container-title":["Interdisciplinary Sciences: Computational Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-026-00835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12539-026-00835-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12539-026-00835-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T16:03:29Z","timestamp":1786550609000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12539-026-00835-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,1]]},"references-count":88,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["835"],"URL":"https:\/\/doi.org\/10.1007\/s12539-026-00835-6","relation":{},"ISSN":["1913-2751","1867-1462"],"issn-type":[{"value":"1913-2751","type":"print"},{"value":"1867-1462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,1]]},"assertion":[{"value":"21 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Author Zunnan Huang is a member of the Editorial Board for\n                      Interdisciplinary Sciences\n                      :\n                      Computational Life Science\n                      s\n                      , and was not involved in the journal\u2019s review of, or decisions related to, this manuscript.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}